DJIA 18,126.12 -36.87 -0.20%
NASDAQ 5,097.98 -8.62 -0.17%
S&P 500 2,120.79 -2.69 -0.13%
market minute promo

166.19 -1.93 (-1.15%)

REAL-TIME: Last trade at

Extended Hours: $165.45 -$0.74 (-0.44%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

ALXN $166.19 -1.15%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $167.22
Previous Close $168.12
Daily Range $164.77 - $168.05
52-Week Range $150.06 - $203.30
Market Cap $33.2B
P/E Ratio 57.58
Dividend (Yield) $0.00 (0.0%)
Volume 1,211,439
Average Daily Volume 2,323,578
Current FY EPS $4.82

Sector

Healthcare

Industry

Drug Makers

Alexion Pharmaceuticals, Inc. (ALXN) Description

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions. Website: http://www.alexionpharm.com/

News & Commentary Rss Feed

Why I'm Buying Sarepta Therapeutics Stock

Sarepta Therapeutics got some great news from the FDA yesterday that sent shares soaring. Here's why the stock is definitely worth a deeper dive by risk-tolerant investors.

Short Sellers Get Even More Ambitious Against Biotech Leaders

Synageva BioPharma Files for Kanuma's Approval in Japan - Analyst Blog

New Strong Sell Stocks for May 26th - Tale of the Tape

'Fast Money' Recap: This Stock Has Risen Every Summer for the Past Decade

Why I Bought The Dips In Both Gilead And Achillion Today

Consolidation Is Good - Cramer's Mad Money (5/18/15)

Biotech Stock Roundup: Alexion to Buy Synageva, FDA Panel Backs Vertex's Orkambi - Analyst Blog

Short Sellers Start to Get Nervous on Biotech

ETFs in Focus on Impressive Q1 Biotech Earnings - ETF News And Commentary

ETFs in Focus on Impressive Q1 Biotech Earnings - ETF News And Commentary

See More ALXN News...

ALXN's Top Competitors

ALXN $166.19 (-1.15%)
Current stock: ALXN
AMGN $157.35 (-1.93%)
Current stock: AMGN
GILD $112.85 (0.35%)
Current stock: GILD
BIIB $400.10 (-0.70%)
Current stock: BIIB